Website
Industry
KANDO id: 14394494
Corporate information
Company type
Multi-strategy investment firm focused on breakthrough biomedical technology companies worldwide.Funding rounds
Investment preferences
Strategy:
Private equity
Investment criteria
Focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, data, tools, and healthcare services and work closely with each portfolio company to build and grow the business from inception to exit.
Stage focus
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
|
Orpheris Inc | Clinical-stage neuroscience company leveraging a platform technology that enabling selective delivery of therapeutic agents across the blood barrier. | N/A Initial investment Exited |